Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Franco Gherlinzoni"'
Autor:
Chiara Concina, Marina Crucil, Emmanouil Theodorakis, Giorgio Saggin, Silvia Perin, Franco Gherlinzoni
Publikováno v:
Clinics in Shoulder and Elbow, Vol 24, Iss 3, Pp 183-188 (2021)
We report a case of a 69-year-old right-dominant man who had an open Monteggia-like lesion of the right elbow (Gustilo-Andersen IIIA) with severe proximal ulna bone loss associated with an ipsilateral ulnar shaft fracture due to a motorcycle accident
Externí odkaz:
https://doaj.org/article/a99f96c8043f4b10a42205edd3865a9c
Publikováno v:
Acta bio-medica : Atenei Parmensis. 92(S3)
Loss of bone stock is the main problem in revision hip arthroplasty. Porous tantalum cups and augment constructs are possible solutions. The aim of this study was to describe results at an average follow-up of 10 years using these cups.25 patients un
Do tourniquet and drainage influence fast track in total knee arthroplasty? Our results on 151 cases
Publikováno v:
Acta bio-medica : Atenei Parmensis
Background: Fast track in total knee replacement (TKR) is a widely used protocol. Tranexamic acid proved to be effective in reducing perioperative bleeding without increasing thromboembolic risk. The aim of this study was to assess if tourniquet and
Publikováno v:
Acta Bio Medica : Atenei Parmensis
Background and aim: Proximal periprosthetic femoral fractures (PPFFs) are gradually increasing and surgical management is often associated to high risk of complications, due to elderly population and associated comorbidities. We retrospectively asses
Autor:
E. Palazzari, Vincenzo Canzonieri, A. De Paoli, G. Bertola, A. Caroli, Angela Buonadonna, Jerry Polesel, M. Gigante, Roberto Innocente, F. Navarria, Franco Gherlinzoni, A. Lauretta
Publikováno v:
Radiotherapy and Oncology. 152:S40
Publikováno v:
Management of Bone Metastases ISBN: 9783319734842
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c6f950413bc40987eb2d70786d54690b
https://doi.org/10.1007/978-3-319-73485-9_9
https://doi.org/10.1007/978-3-319-73485-9_9
Autor:
Enrico Aitini, Maurizio Bendandi, Alfonso Zaccaria, Sante Tura, Pier Luigi Zinzani, Marzia Salvucci, Franco Gherlinzoni
Publikováno v:
European Journal of Haematology. 54:120-123
Fludarabine (FLU) is a fluorinated purine analogue with a promising antineoplastic activity in lymphoproliferative disorders. In this study, we evaluated the efficacy of FLU in 12 previously treated (primary refractory and refractory relapse) patient
Autor:
Robert J. Grimer, Antonie H. M. Taminiau, Cristina Ferrari, Yehuda Kollender, Franco Gherlinzoni, Georg Gosheger, Zdenek Matejovsky, David Biau, Mikel San-Julian
Publikováno v:
European Journal of Cancer. 43:2060-2065
Background Dedifferentiated chondrosarcoma has a very poor prognosis. Because of its rarity, there are few large studies of outcome which might identify potential prognostic factors. In particular there remains uncertainty about the value of chemothe
Autor:
D. Ielo, Mario Cazzola, A. De Vivo, Mario Petrini, G. Fioritoni, Simona Sica, Fausto Castagnetti, B. Falini, Miriam Fogli, Agostino Cortelezzi, C. Viganò, Giuliana Alimena, Maurizio Musso, G. Spinosa, Flavia Salvi, Giancarlo Latte, Michele Pizzuti, Nicola Cantore, D. Luzzi, B. Ronci, Francesco Merli, Mario Boccadoro, Diamante Turri, Monica Bocchia, Patrizia Tosi, A. M. Carella, Simona Luatti, G. Semenzato, Mariella Grasso, Nicoletta Testoni, Giovanni Martinelli, Ester Pungolino, Giuseppe Tagariello, A. Russo Rossi, Simona Soverini, Francesca Ronco, Franco Iuliano, Giovanni Rosti, Alberto Bosi, Tamara Intermesoli, Dario Ferrero, Sara Galimberti, Giovanna Rege-Cambrin, Ferdinando Porretto, Sabina Russo, Roberto Latagliata, Pellegrino Musto, E. Morra, Agostino Tafuri, Franca Falzetti, Francesco Cavazzini, P. Galieni, Marzia Salvucci, F. Rodighiero, Stefana Impera, Fausto Dore, P. De Fabritiis, V. Meneghini, Elisabetta Calistri, Paolo Vigneri, Ivana Pierri, Michele Cavo, Massimo Pini, Fabrizio Ciccone, Domenico Russo, E Trabacchi, Franco Gherlinzoni, Michele Baccarani, Ilaria Iacobucci, Roberto Sartori, Paolo Avanzini, D. Noli, Roberto Marasca, Simonetta Pardini, A. Malpignano, Maria Concetta Petti, Bruno Martino, M. Bergamaschi, Giovanni Pizzolo, Valeria Santini, E Orlandi, Catia Bigazzi, Serena Rupoli, Giuseppe Saglio, I. Cervello, Clementina Caracciolo, Anna Merli, R. Di Lorenzo, Enrico Pogliani, Francesco Lanza, Mariella Girasoli, M. Apolinari, Caterina Musolino, Francesco Fabbiano, D. Vallisa, Mario Annunziata, Gabriele Gugliotta, V. De Stefano, Ignazio Majolino, Sergio Storti, P. Leoni, Adele Capucci, Massimo Breccia, Alessandro Isidori, Carmen Fava, Gianni Binotto, Carlo Gambacorti-Passerini, L. Pacilli, Mario Tiribelli, Luciano Levato, Felicetto Ferrara, N. Di Renzo, Anna D'Emilio, Francesco Pisani, Fabio Stagno, Monica Crugnola, M. Trawiska, Patrizia Pregno, Marzia Defina, Stefano Molica, Mario Luppi, Michele Malagola, Davide Rapezzi, A. M. Liberati, E. De Biasi, A. Iurlo, Umberto Vitolo, Silvana Capalbo, Maria Teresa Bochicchio, F. Di Raimondo, Franco Aversa, Giuseppe Visani, Fausto Palmieri, Alessandro Rambaldi, Sergio Siragusa, Massimiliano Bonifacio, Luigiana Luciano, Giorgina Specchia, Elisabetta Abruzzese, A. De Blasio, Francesco Albano, Antonio Cuneo, Emilio Usala, Alfonso Zaccaria, R Fanin, Francesca Palandri, Fabrizio Pane, Enrico Montefusco, A. Gozzini, Giulio Rossi, Emanuele Angelucci, A. Bacigalupo, Marco Gobbi, Michele Cedrone
BACKGROUND: The incidence of chronic myeloid leukemia (CML) increases with age, but it is unclear how the characteristics of the disease vary with age. In children, where CML is very rare, it presents with more aggressive features, including huge spl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03825110771412a534fa417f8a805790
http://hdl.handle.net/2158/1046242
http://hdl.handle.net/2158/1046242
Autor:
Vittorio Stefoni, Enrico Aitini, Monica Tani, Vito Michele Lauta, Enzo Pavone, Luciano Moretti, Franco Gherlinzoni, Luciano Guardigni, Fabrizio Ciccone, Lapo Alinari, Brunangelo Falini, Sante Tura, Michele Baccarani, Ettore Volpe, Francesco Lauria, Pierpaolo Fattori, Patrizio Mazza, Sergio Storti, A De Renzo, Pier Luigi Zinzani, Patrizia Gentilini, Francesco Zaja, Donato Mannina, Alfonso Zaccaria
Publikováno v:
Annals of Oncology. 13:1364-1369
Background Among the third-generation chemotherapy regimens specifically adapted in the last decade for elderly aggressive non-Hodgkin’s lymphoma (NHL) patients, we designed an 8-week cyclophosphamide, mitoxantrone, vincristine, etoposide, bleomyci